Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    8195181 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Rapid Screening Phenotype Test To Evaluate CYP 2C19 Enzyme Activity Using Stable Isotope [13C]Pantoprazole
Condition: Healthy
Intervention: Drug: [13C]Pantoprazole
2 Enrolling by invitation Treatment Effect Between Dexlansoprazole and Double-dose Lansoprazole in Obesity Patients With Reflux Esophagitis
Condition: Gastroesophageal Reflux Disease
Interventions: Drug: Dexlansoprazole;   Drug: Lansoprazole

Study has passed its completion date and status has not been verified in more than two years.